今日药学

2019, v.29(01) 69-72

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

恶性肿瘤治疗的经济毒性研究进展
Progress on Financial Toxicity in Cancer Treatment

周娟;张健辉;李佩雯;冯霞;王若伦;
ZHOU Juan;ZHANG Jianhui;LI Peiwen;FENG Xia;WANG Ruolun;the Second Affiliated Hospital of Guangzhou Medical University;School of Pharmaceutical Sciences,Guangzhou Medical University;

摘要(Abstract):

在新型抗癌药物和治疗技术的辅助下,癌症患者的生存期和生活质量均得到较大改善,但代价是高额的医疗成本。有证据表明,相当大比例的癌症患者受到与治疗相关的经济负担的影响,这是普遍存在的问题,却未得到重视。在恶性肿瘤治疗过程中仅仅关注药物相关的不良反应是不够的,经济毒性(financial toxicity)同样给患者的生活造成巨大的困扰,严重者可能会加速患者的死亡。经济毒性已被列为恶性肿瘤治疗的潜在不良反应之一,但在我国尚未被广泛认知,笔者就恶性肿瘤治疗的经济毒性研究进展进行综述。
The survival and quality of life of patients with cancer have been greatly improved with the available of new anticancer drugs and therapies,but at the expense of high medical costs. Evidence suggests that a considerably large proportion of cancer patients are affected by treatment-related financial burden,but it has not been paid enough attention.Only focus on drug related adverse reaction is not enough in cancer treatment. Financial toxicity also causes great distress in patients' lives,and may shorten patients survival.Financial toxicity has been listed as one of the potential adverse reactions to cancer therapy,but it has not been widely recognized in China. So the authors reviews the progress of financial toxicity in cancer treatment.

关键词(KeyWords): 恶性肿瘤;经济毒性;治疗
cancer;financial toxicity;treatment

Abstract:

Keywords:

基金项目(Foundation): 广东省医院药学研究基金资助项目(2015A12)

作者(Author): 周娟;张健辉;李佩雯;冯霞;王若伦;
ZHOU Juan;ZHANG Jianhui;LI Peiwen;FENG Xia;WANG Ruolun;the Second Affiliated Hospital of Guangzhou Medical University;School of Pharmaceutical Sciences,Guangzhou Medical University;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享